Wilmington, Delaware, United States, Transparency Market Research, Inc. , Oct. 22, 2024 (GLOBE NEWSWIRE) -- The hemostatic agents industry (Industrie für blutstillende Mittel) was worth US$ 2.6 ...
Results from a genome-wide association study indicate blood clot factors may contribute to the cause of migraine with aura. Although migraineurs who suffer from MA—or flashing lights, blind spots, or ...
A hemostatic powder, TC-325 (Hemospray), worked as well as standard treatment for endoscopic control of acute bleeds from nonvariceal upper gastrointestinal lesions, a randomized trial found. In the ...
A topical hemostatic patch placed beneath a standard air-bladder bracelet significantly cuts down on the time to hemostasis after transradial procedures without increasing the risk of radial artery ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
NEW ORLEANS, LA—Recombinant factor VIIa slowed hematoma growth in patients with a spontaneous intracerebral hemorrhage (ICH) when administered within 2 hours of onset, but treatment significantly ...
NEW ORLEANS -- There is still hope that recombinant factor VIIa (rFVIIa) may be a good hemostatic treatment for acute intracerebral hemorrhage (ICH) under the right circumstances -- just not the way ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results